Trevena

IPO

Trevena is a biotech company in King of Prussia, United States, founded in 2007. It has raised $95.0M across 2 rounds, most recently a $35.0M Series B in July 2010.

Trevena, Inc.

Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$95.0M
Last Round
$35.0M Series BJul 2010
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with central nervous system (CNS) disorders. The company's novel pipeline is based on Nobel Prize winning research and includes four novel and differentiated drug development programs. OLINVYK is approved by the FDA. Investigational candidates include TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, and TRV045, a novel S1P receptor modulator that may offer a non-opioid approach to treating diabetic neuropathic pain, epilepsy, and other CNS disorders.

Summary

It lists 51–200 employees. It has raised $95.0M in total across 2 rounds, most recently a $35.0M Series B round in Jul 2010. Investors include Polaris Partners.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOFeb 2014
$64.8M

Sign up to see all 3 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trevena on Indexed.vc
<a href="https://indexed.vc/companies/trevena"><img src="https://indexed.vc/api/badge/company/trevena" alt="Trevena on Indexed.vc" width="260" height="76" /></a>